Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
- PMID: 26807007
- PMCID: PMC4714724
- DOI: 10.2337/diaclin.34.1.34
Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
Abstract
In Brief This article explores some of the reasons for the delay in insulin initiation in primary care and evaluates new approaches to insulin therapy that may address these barriers and, therefore, improve insulin use by primary care providers.
Similar articles
-
Identification of barriers to insulin therapy and approaches to overcoming them.Diabetes Obes Metab. 2018 Mar;20(3):488-496. doi: 10.1111/dom.13132. Epub 2017 Nov 22. Diabetes Obes Metab. 2018. PMID: 29053215 Free PMC article. Review.
-
Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review.Diabetes Spectr. 2023 Fall;36(4):379-384. doi: 10.2337/ds22-0084. Epub 2023 Jun 23. Diabetes Spectr. 2023. PMID: 38024219 Free PMC article.
-
Barriers and Attitudes of Primary Healthcare Physicians to Insulin Initiation and Intensification in Saudi Arabia.Int J Environ Res Public Health. 2022 Dec 14;19(24):16794. doi: 10.3390/ijerph192416794. Int J Environ Res Public Health. 2022. PMID: 36554673 Free PMC article.
-
Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.Ann Med. 2018 Sep;50(6):453-460. doi: 10.1080/07853890.2018.1493216. Epub 2018 Aug 25. Ann Med. 2018. PMID: 30103624 Review.
-
Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".J Assoc Physicians India. 2017 Jul;65(7):51-62. J Assoc Physicians India. 2017. PMID: 28792170
Cited by
-
Insulin Initiation and Titration in Patients With Type 2 Diabetes.Diabetes Spectr. 2019 May;32(2):104-111. doi: 10.2337/ds18-0005. Diabetes Spectr. 2019. PMID: 31168280 Free PMC article.
References
-
- Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995;18:258–268 - PubMed
-
- UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
-
- Asche CV, Bode B, Busk AK, Nair SR. The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus. Diabetes Obes Metab 2012;14:47–57 - PubMed
-
- American Diabetes Association Standards of medical care in diabetes—2015. Diabetes Care 2015;38(Suppl. 1):S1–S92 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources